Ketamine Versus Dexmedetomidine in Supraclavicular Brachial Plexus Block
Status:
Recruiting
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
Intervention model description: The patients were randomly classified into three groups using
computer-generated table numbers each contain (25) patients.
Ketamine group (group K): 20 ml 0.5%bupivacaine and 20 ml 0.9% normal saline plus 1 mg\kg
ketamine, Dexmedetomidine group (group D): 20 ml 0.5% bupivacaine and 20 ml 0.9% normal
saline plus 1µg\kg dexmedetomidine Control group (group C): 20 ml 0.5%bupivacaine and 20 ml
0.9% normal saline. Masking: double-blind (participant and investigator) Masking Description:
The investigator's study is a prospective, randomized, double-blind